Changes in lung function in European adults born between 1884 and 1996 and implications for the diagnosis of lung disease: a cross-sectional analysis of ten population-based studies:

ames P Allinson, PhD Shoaib Afzal, DMSc Yunus Çolak, PhD Debbie Jarvis, MD Helena Backman, PhD Maarten van den Berge, PhD et al.

4 October, 2021

NZ Respiratory Research Review Issue 192

Diagnostic accuracy of focused deep venous, lung, cardiac and multiorgan ultrasound in suspected pulmonary embolism: a systematic review and meta-analysis:

Casper Falster, Niels Jacobsen, Karen Ehlers Coman, Mikkel Højlund, Thomas Agerbo Gaist, Stefan Posth, Jacob Eifer Møller, Mikkel Brabrand, Christian B Laursen

8 September, 2021

NZ Respiratory Research Review Issue 202

Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model:

Jan Heyckendorf, Sebastian Marwitz, Maja Reimann, Korkut Avsar, Andrew R. DiNardo, Gunar Günther, Michael Hoelscher, Elmira Ibraim, Barbara Kalsdorf, Stefan H.E. Kaufmann, Irina Kontsevaya, Frank van Leth, Anna M. Mandalakas, Florian P. Maurer, Marius Müller, Dörte Nitschkowski, Ioana D. Olaru, Cristina Popa, Andrea Rachow, Thierry Rolling, Jan Rybniker, Helmut J.F. Salzer, Patricia Sanchez-Carballo, Maren Schuhmann, Dagmar Schaub, Victor Spinu, Isabelle Suárez, Elena Terhalle, Markus Unnewehr, January Weiner, Torsten Goldmann and Christoph Lange

2 September, 2021

NZ Respiratory Research Review Issue 199

Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism:

Ana Jaureguízar, MD David Jiménez, MD, PhD Behnood Bikdeli, MD Gili Kenet, MD Manuel Monreal, MD, PhD

31 August, 2021

NZ Respiratory Research Review Issue 202

Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial:

Prof Stephan Rosenkranz, MD Prof Jeremy Feldman, MD Prof Vallerie V McLaughlin, MD Prof Franz Rischard Dr Tobias J Lange, MD Prof R James White, MD et al

20 August, 2021

NZ Respiratory Research Review Issue 195

Indoor Air Pollution and Susceptibility to Tuberculosis Infection in Urban Vietnamese Children:

Robert J. Blount, Ha Phan, Trang Trinh, Hai Dang, Cindy Merrifield, Michael Zavala, Joseph Zabner, Alejandro P. Comellas, Emma M. Stapleton, Mark R. Segal, John Balmes, Nguyen Viet Nhung, and Payam Nahid

3 August, 2021

NZ Respiratory Research Review Issue 199

Effect of quitting smoking on health outcomes during treatment for tuberculosis: secondary analysis of the TB & Tobacco Trial:

Kamran Siddiqi, Ada Keding, Anna-Marie Marshall, Omara Dogar, Jinshuo Li, Rumana Huque, Razia Fatima, Amina Khan, Helen Elsey, Rhian Gabe, Daniel Kotz, Aziz Sheikh

16 July, 2021

NZ Respiratory Research Review Issue 199

Risk and impact of chronic cough in obese individuals from the general population:

Eskild Morten Landt, Yunus Çolak, Børge G Nordestgaard, Peter Lange, Morten Dahl

6 July, 2021

NZ Respiratory Research Review Issue 203

An Original Risk Score to Predict Early Major Bleeding in Acute Pulmonary Embolism - The Syncope, Anemia, Renal Dysfunction (PE-SARD) Bleeding Score:

Romain Chopard, MD, PhD Gregory Piazza, MD Nicolas Falvo, MD Fiona Ecarnot, PhD Mathieu Besutti, MD Gilles Capellier, MD, PhD François Schiele, MD, PhD Marc Badoz, MD Nicolas Meneveau, MD, PhD

1 July, 2021

NZ Respiratory Research Review Issue 195

Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial:

Kevin L. Winthrop, Patrick A. Flume, Rachel Thomson, Kevin C. Mange, Dayton W. Yuen, Monika Ciesielska, Kozo Morimoto, Stephen J. Ruoss, Luigi R. Codecasa, Jae-Joon Yim, Theodore K. Marras, Jakko van Ingen,Richard J. Wallace, Jr., Barbara A. Brown-Elliott, Chris Coulter, and David E. Griffith*; for the INS-312 Study Group

1 July, 2021

NZ Respiratory Research Review Issue 199